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Humoral Immunity
Due to Long-Lived Plasma Cells
unlike memory B cells, mature plasma cells are unlikely
to participate in antigen processing and presentation.
Instead, the main function of a plasma cell is to continu-
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Department of Microbiology and Immunology ously secrete large quantities of specific antibody.
Plasma cell secretion rates have been estimated to beEmory University School of Medicine
²Department of Biology as high as 10,000 molecules/second (Helmreich et al.,
1961; Hibi and Dosch, 1986). In contrast, memory B cellsEmory University
Atlanta, Georgia 30322 do not spontaneously secrete antibody; rather, following
appropriate stimulation, these cells proliferate and dif-
ferentiate into antibody-secreting cells (ASC). Because
protection against microbial infection often relies on theSummary
level of preexisting antibody in the serum or mucosal
surfaces, the number and specificity of preexistingConventional models suggest that long-term antibody
plasma cells are critical components of protective im-responses are maintained by thecontinuous differenti-
munity.ation of memory B cells into antibody-secreting plasma
The mechanisms underlying long-term antibody pro-cells. This is based on the notion that plasma cells are
duction are not fully understood, but the conventionalshort-lived and need to be continually replenished by
model postulates that the maintenance of serum anti-memory B cells. We examined the issue of plasma
body requires the continuous proliferation and differen-cell longevity by following the persistence of LCMV-
tiation of memory B cells into antibody-secreting plasmaspecific antibody and plasma cell numbers after in vivo
cells (Szakal et al., 1989; Tew et al., 1990; MacLennandepletion of memory Bcells and by adoptive transfer of
et al., 1992; Stites et al., 1994; Gray et al., 1996; Zinkerna-virus-specific plasma cells into naive mice. The results
gel et al., 1996). This model is based on the belief thatshow that a substantial fraction of plasma cells can
plasma cells are short-lived. Although an early studysurvive and continue to secrete antibody for extended
(Miller, 1964) had suggested that some plasma cellsperiods of time (.1 year) in the absence of any detect-
may survive for several months, current immunologicalable memory B cells. This study documents the exis-
dogma holds that plasma cells have a half-life of onlytence of long-lived plasma cells and demonstrates a
a few days (Cooper, 1961; Schooley, 1961; Makela andnew mechanism by which humoral immunity is main-
Nossal, 1962; Nossal and Makela, 1962; Levyet al., 1987)tained.
to at most a few weeks (Ho et al., 1986). Such rapidly
dying cells would of course require repopulation byIntroduction
memory B cells in order to sustain ongoing humoral
responses.Antibodies provide the first line of defense against infec-
In this study, we have reinvestigated this issue andtion by microbial pathogens, and it is not coincidental
show that plasma cellsare long-livedand that a substan-that many of the currently used vaccines that confer
tial fraction of these terminally differentiated cells canlong-term protective immunity also induce prolonged
survive for the life of the mouse. We have found thathumoral responses (Plotkin and Mortimer, 1988; Ahmed
long-lived plasma cells are present in the bone marrowand Gray, 1996; Slifka and Ahmed, 1996b). For example,
as well as in the spleen. Consistent with our findings, aimmunization with live viral vaccines such as those
recent study (Manz et al., 1997) that examined plasmaagainst measles, polio, and yellow fever, or even inert
vaccines such as those against tetanus or diphtheria cell longevity in the bone marrow showed that plasma
toxoid, result in circulating antibody in the serum that cells can survive for more than 90 days without turnover.
can be detected for decades (Plotkin and Mortimer, Our study, as well as that by Manz et al., documents
1988; Slifka and Ahmed, 1996b). Since the half-life of the importance of plasma cells in maintaining long-term
free immunoglobulin (Ig) is less than 3 weeks (Fahey antibody production and challenges the presently popu-
and Sell, 1965; Talbot and Buchmeier, 1987; Vieira and lar concept that plasma cells are short-lived.
Rajewsky, 1988), continuous antibody production is
necessary to sustain antigen-specific Ig levels in the
serum. Results
The majority of serum antibody is produced by termi-
nally differentiated plasma cells. These nondividing cells Humoral Response to Viral Infection
differ from memory B cells in many respects. For in- The role of plasma cells in maintaining long-term anti-
stance, plasma cells down-regulate surface expression body production was examined using the mouse model
of many typical B cell markers, including major histo- of infection with lymphocytic choriomeningitis virus
compatibility (MHC) class II and surface Ig (Abney et al., (LCMV) (Oldstone and Dixon, 1967; Oldstone et al., 1985).
1978; Halper et al., 1978). These changes indicate that, Adult mice infected with LCMV (Armstrong strain) make
vigorous antiviral T and B cell responses and clear the
virus within 2 weeks (Ahmed et al., 1988; Lau et al., 1994;³To whom correspondence should be addressed (e-mail: ra@
microbio.emory.edu). Slifka et al., 1995). These acutely infected mice then
Immunity
364
kinetics were observed in the lymph nodes (data not
shown). In contrast, LCMV-specific plasma cells were
not detected in the bone marrow at 8 days postinfection,
but as splenic populations declined, an increasing num-
ber of plasma cells accumulated in the bone marrow.
After day 30 and for the life of the mouse, the bone
marrow contained 2 3 104 to 3 3 104 virus-specific ASC.
This indicates that bone marrow is the predominant site
of antiviral antibody production, with nearly 90% of vi-
rus-specific plasma cells residing in this compartment
(Slifka et al., 1995). Similar results have been obtained
with otherviral infections (Bachmann et al., 1994; Hyland
et al., 1994) and after booster vaccination with inert
antigens (Benner et al., 1981; Dilosa et al., 1991; Smith
et al., 1997).
Since memory B cells, by definition, do not spontane-
ously secrete antibody directly ex vivo, memory B cell
numbers were quantitated after6 days of in vitro stimula-
tion with virus. This induced virus-specific B cells from
LCMV-immune mice (but not from naive mice) toprolifer-
ate and differentiate into ASC (Slifka and Ahmed, 1996a).
Quantitation of LCMV-specific memory B cell numbers
was performed in vitro by limiting dilution analysis. In
contrast to the migration of ASC to the bone marrow,
LCMV-specific memory B cells were identified mostly
in the spleen and lymph nodes of infected mice (Figure
1C). The total number of memory B cells per spleen
increased from approximately 1.5 3 103 at day 8 postin-
fection to approximately 5 3 103 by day 60. This indi-
cates that a memory B cell frequency of about 1 per 2
3 104 was maintained for longer than 300 days afterFigure 1. Kinetics of the Humoral Response Following Acute LCMV
Infection infection. Virus-specific memory B cells were also identi-
Adult BALB/c mice (6±8 weeks old) were infected intraperitoneally fied in the lymph nodes (frequency 1 per 6 3 103) and
with 2 3 105 pfu of LCMV Armstrong and analyzed for the presence peripheral blood (1 per 2 3 105), but were not detected
of virus-specific antibody in the serum (A) and the number of LCMV- in the bone marrow (,1 per 3 3 105) by limiting dilution
specific ASC (B) or memory B cells (MBC) (C) in the spleen and analysis.
bone marrow. Virus-specific IgG in the serum was determined by
ELISA (Ahmed et al., 1984) and measured in ELISA units. LCMV-
Memory B Cell Depletion In Vivospecific plasma cells were quantitated by ELISPOT assay (Slifka et
It is evident from Figure 1 that LCMV-immune mice main-al., 1995) and are defined as cells that lack detectable surface Ig
and MHC class II molecules (Abney et al., 1978; Halper et al., 1978) tain stable populations of both virus-specific memory B
and spontaneously secrete large amounts of specific antibody di- cells and plasma cells. The relatively constant pool of
rectly ex vivo without restimulation by antigen. Memory B cells were ASC provides the high level of virus-specific antibody in
analyzed by limiting dilution analysis (Slifka and Ahmed, 1996a) and the serum, buthow are these ASC numbers maintained?
are defined as surface Ig1MHC class II1 cells that do not spontane-
Does this maintenance reflect a population of long-livedously secrete antibody but proliferate and differentiate into anti-
plasma cells, or are these cells dying rapidly and beingbody-secreting plasma cells following restimulation with antigen.
replenished by the stimulation of memory B cells? ToThe data shown represent the average of three to six mice at each
timepoint. address this question, we depleted memory B cells in
vivo and monitored virus-specific antibody titers and
plasma cell numbers when there was no longer a mem-
continue to maintain high levels of virus-specific anti- ory B cell pool present to repopulate dying plasma cells.
body in the serum for life (Figure 1A) (Moskophidis and To deplete memory B cells in vivo, adult LCMV-
Lehmann-Grube, 1984; Slifka et al., 1995). immune mice (.60 days postinfection) were given 600
To characterize the antibody response further and to rad of total body irradiation. Within 24hr after irradiation,
examine the dynamics of plasma cells and memory B this dose depleted more than 95% of total lymphocytes
cells in sustaining long-term antibody production, we from the spleen and the lymph nodes (data not shown).
quantitated the number of virus-specific plasma cells Previous studies have shown that 500±600 rad of whole-
and memory B cells present in LCMV-infected mice. As body irradiation effectively eliminates antigen-specific
shown in Figure 1B, the initial plasma cell response memory B cell responses in vivo (Makinodan et al., 1962;
occurred in the spleen and peaked at day 8 postinfec- Okudaira and Ishizaka, 1981) and that memory B cells
tion, with 6 3 104 ASC perspleen. Thereafter, thenumber and naive B cells are equally radiosensitive (Anderson
of virus-specific ASC declined to 3 3 103 ASC/spleen, and Lefkovits, 1980). In our studies, LCMV-specific
indicating a 95% reduction in numbers by 30 days post- memory B cell depletion was confirmed by several tech-
infection. LCMV-specific ASC in the spleen then per- niques. Functional analysis, such as limiting dilution ex-
periments, showed that novirus-specific memory B cellssisted at this level for more than 300 days. Similar ASC
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Table 1. In Vivo Depletion of LCMV-Specific Memory B Cells by g-irradiation
Number of
Group Number of Mice Days Postirradiation Reconstitutiona Cells/spleen Frequency of Memory B Cellsb
LCMV-immune 25 No irradiation None 8.9 3 107 1 per 2.0 3 104 (6 0.5 3 104)
Naive 4 No irradiation None 9.4 3 107 ,1/106
LCMV-immune 3 1 None 0.4 3 107 ,1/106
3 1 IgHb 1.8 3 107 ,1/106
3 15 IgHb 8.4 3 107 ,1/106
3 30 IgHb 7.9 3 107 ,1/106
3 50 IgHb 8.4 3 107 ,1/106
3 146 IgHb 5.3 3 107 ,1/106
4 240 IgHb 5.7 3 107 ,1/106
BALB/c mice (IgHa) were infected with 2 3 105 pfu LCMV Armstrong at 6±8 weeks of age. At 60 days postinfection, mice received 600 rad of
total-body irradiation to deplete memory B cells.
a Within 4 hr postirradiation, mice were reconstituted with allotypic BALB/c IgHb spleen and bone marrow cells.
b After irradiation, the splenic memory B cell frequency dropped below detection (,1 memory B cell per 106 spleen cells) as determined by
limiting dilution analysis. Likewise, LCMV-specific memory B cells were no longer detected in the lymph nodes after irradiation, and the
absence of memory B cells was confirmed by adoptive transfer/challenge experiments.
(,1 per 106 spleen cells) could be detected in irradiated virus-specific memory B cells and lacking antigen to
stimulate naive B cells.mice (Table 1). In addition, adoptive transfer and chal-
lenge experiments indicated that memory B cell num-
bers had fallen to below the level of detection. Transfer Antibody Titer and Plasma Cell Lifespan
in the Absence of Memory B Cellsof 2 3 107 spleen cells from irradiated immune mice
resulted in undetectable titers by enzyme-linked immu- The levels of virus-specific antibody in the sera of irradi-
ated/reconstituted LCMV-immune BALB/c mice werenosorbent assay (ELISA) (,30 ELISA units) at day 7
postchallenge, in contrast to transfer of the same num- monitored for an 8-month period (Figure 2). Although
antibody titers showed a gradual decline, it was strikingber of LCMV-immune spleen cells, which resulted in
high ELISA titers (50,400 ELISA units). that high levels of virus-specific antibody were still pres-
ent in the serum even 8 months after memory B cellTo monitor thedepletion of host B cells visually, irradi-
atedLCMV-immune BALB/c (IgHa) mice were reconstitu- depletion. The LCMV-specific antibody was entirely of
the host IgHa allotype, showing that virus-specific anti-ted with B and T lymphocytes plus bone marrow cells
from naive congenic BALB/c IgHb mice on the day of body production was maintained solely by preexisting
host plasma cells. No virus-specific antibody of the do-irradiation. The lymphoid tissues of these irradiated/
reconstituted mice consisted almost exclusively of do- nor IgHb allotype could be detected. This provided addi-
tional evidence that there was no priming of naive B cellsnor IgHb-bearing B cells (Figure3C). Following irradiation
and reconstitution, no LCMV-specific memory B cells in irradiated/reconstituted LCMV-immune mice (Figure
2A). Persistence of host IgHa virus-specific antibody inwere detected (Table 1), indicating that not only were the
host's preexisting memory B cells depleted, but naive the serum was not due to residual, preexisting virus-
specific Ig, since passive transfer of LCMV-immune se-donor (IgHb) B cells were not primed into becoming part
of the memory B cell pool. Also, rechallenge of irradi- rum into naive recipients demonstrated a rapid rate of
decline (IgG half-life [t1¤2] 5 11.7 6 0.5 days).ated/reconstituted LCMV-immune mice with the same
strain of LCMV failed to induce an anamnestic response, Analysis of the dynamics of serum antibody titers fol-
lowing irradiation provides a quantitative estimation ofagain indicating that memory B cell populations had
droppedto below the level of detection (data not shown). the rate of plasma cell loss in vivo. Since irradiation
eliminates the memory B cell population and kills onlyTaken together, these results not only demonstrate that
host memory B cells were effectively depleted, but also a fraction of plasma cells, we expected the antibody
titer to follow a biexponential decay. The initially rapidshow that irradiated LCMV-immune mice did not contain
a depot of viral antigen capable of priming naive B cells. decay of serum antibody is a consequence of the loss
of a fraction of the plasma cells upon irradiation, fol-In contrast to memory B cells, which are easily de-
pleted by irradiation (Makinodan et al., 1962; Anderson lowed by a slower decay that reflects the rate of loss
of surviving plasma cells in the absence of renewal byand Lefkovits, 1980; Okudaira and Ishizaka, 1981),
plasma cells are notably radiation resistant (Makinodan memory B cells. Using a mathematical model of decay
that incorporates these processes (see Experimentalet al., 1967; Okudaira and Ishizaka, 1981). Analysis by
the enzyme-linked immunospot (ELISPOT) technique 1 Procedures), we obtained estimates of the fraction of
plasma cells lost upon irradiation as well as estimatesday after irradiation revealed a drop of 2-fold or less in
the total number of virus-specific plasma cells in the of the lifespan of plasmacells. The LCMV-specific serum
IgG data indicated a mean plasma cell t1¤2 of 138 days.bone marrow and spleen (Figure 3A). Thus, total body
irradiation (followed by allotypic B cell reconstitution) Similar results (t1¤2 5 141 days) were obtained by fitting
a simple exponential decay curve to the antibody titersprovided a simple in vivo system for monitoring the
persistence of virus-specific serum antibody and plasma obtained after the first 30 days following irradiation. To
characterize this result further, the half-life of plasmacell numbers in an environment containingno detectable
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To determine the half-life of LCMV-specific plasma
cells directly, we used the ELISPOT technique to quanti-
tate individual IgG-producing virus-specific ASC in the
bone marrow and spleens of irradiated/reconstituted
mice. The results of this analysis are summarized in
Figure 3A. Similar to the estimates obtained from serum
antibody titers (Figure 2), direct quantitation of ASC
numbers indicated that LCMV-specific plasma cells de-
cay exponentially, with a mean t1¤2 of 94 days (range
85±105 days) in the bone marrow and 172 days (range
149±202 days) in the spleen. The actual data from the
day 240 time point are shown in Figures 3B±3D. Figure
3B shows that LCMV-specific plasma cells in irradiated/
reconstituted mice were entirely of the host (IgHa) allo-
type even though all of the B cells in these mice were
of donor origin (IgHb). In other words, these mice were
essentially (IgHb) mice in terms of their B cells, but all
of the LCMV-specific ASC were of IgHa allotype (i.e.,
were present before irradiation and had survived .240
days after irradiation). Besides demonstrating that the
long-lived ASC were of host origin, we also determined
whether thesecells maintained a plasma cellphenotype,
as indicated by the presence of little to no surface-
bound Ig or MHC class II molecules (Abney et al., 1978;
Halper et al., 1978). As shown in Figure 3D, removal of
MHC class II± or surface Ig±bearing cells (by adherence
to antibody-coated plates) did not result in a reduction
in the number of LCMV-specific ASC. Thus, these ASC
had a surface phenotype (MHC class IIlo/2 Iglo/2) charac-
teristic of plasma cells. Finally, no memory B cells (either
IgHa or IgHb) were detected in these mice (Table 1).
These results show that a substantial number of plasma
cells can survive for longer than 8 months without re-
plenishment by memory B cells. It is worth emphasizing
Figure 2. Virus-Specific Antibody Production after Memory B Cell
that the half-life of plasma cells calculated by the ELIS-Depletion
POT assay was not substantially different from the half-
At 60 days postinfection, LCMV-immune BALB/c IgHa mice were
life estimated from serum antibody titers. This suggestsirradiated to deplete memory B cells and then reconstituted with
not only that plasma cells are long-lived, but also thatnaive BALB/c IgHb B cells. The levels of LCMV-specific IgG (A), IgG1
(B), and IgG2a (C) in the serum of these mice were determined the rate of antibody production per plasma cell does not
by ELISA (Ahmed et al., 1984). LCMV-specific antibody consisted appear to wane even after several months of continuous
entirely of the host IgHa allotype; no donor IgHb (IgG2ab) antibody antibody production.
responses were detected. The half-life of plasma cells was obtained
To extend our studies, we also looked at plasma cellby fitting the data for antibody concentration A[t] in individual mice
longevity in another mouse strain, C57BL/6 Thy1a IgHato a biexponential decay described by the function A(t) 5 [A(0)/(a 2
mice. Similar to the BALB/c strain, C57BL/6 Thy1a IgHap)][a(1 2 f)e2pt 1 (af 2 p)e2at]. The decay rate of free Ig was deter-
mined by passively transferring LCMV-immune serum into naive mice cleared acute LCMV Armstrong infection within 2
recipients and monitoring the decline in serum antibody levels by weeks (data not shown). At 80 days postinfection, these
ELISA (opentriangles, circles, and diamonds represent three individ- mice were depleted of memory B cells by administration
ual recipient mice). The mean values (6 1 SEM) for the half-lives of of a high dose (800 rad) of g-radiation. This treatment
transferred Ig were t1¤2 (total IgG), 11.7 6 0.5 days; t1¤2 (IgG1), 14.4 6
was followed by reconstitution with naive allotypic0.4 days; and t1¤2 (IgG2a), 13 6 1 days.
C57BL/6 (IgHb) B cells, T cells, and bone marrow. Similar
to the previous irradiation/reconstitution experiments,
cells making LCMV-specific antibody of the IgG1 and no donor (IgHb) LCMV-specific antibody was detected,
IgG2a subclasses was also determined. Using the biex- indicating again that there was no viral antigen remaining
ponential decay model, we obtained a mean t1¤2 of 140 that was capable of eliciting a detectable antibody re-
days for IgG1-secreting plasma cells and a t1¤2 of 128 sponse by naive B cells (data not shown). In addition,
days for IgG2a-secreting plasma cells. IgG1 production host memory B cell frequencies dropped to below the
usually indicates a helper T cell type 2 (Th2)±type cyto- level of detection (,1 memory B cell per 106 spleen cells)
kine response, whereas IgG2a production is indicative of following irradiation. After depletion of the memory B
a Th1-type response (Romagnani, 1997). These results cell pool, virus-specificserum antibody titers were main-
therefore show that long-lived plasma cells are gener- tained for more than 500 days, and although serum anti-
ated during both Th1 and Th2 responses and that these body titers declined over time (t1¤2 5 80 days, range 5
subclasses of ASC appear to have remarkably similar 70±93 days), an impressive level of virus-specific anti-
body was still observed nearly 1.5 years after irradiationhalf-lives in vivo.
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Figure 3. Plasma Cell Survival after Memory B Cell Depletion
(A) Plasma cells were quantitated in the spleen and bone marrow of irradiated/reconstituted LCMV-immune mice and compared to nonirradiated
immune mice using an ELISPOT assay (Slifka et al., 1995). The data are presented as a ratio of the number of LCMV-specific ASC observed
in irradiated mice divided by the average number of ASC observed in nonirradiated control mice (three or four control mice per time point).
The ratio of virus-specific ASC in the spleen (open circles) and bone marrow (BM) (closed circles) of individual irradiated mice are shown at
the indicated time points. The decay rate of plasma cell numbers was obtained from the slope of the log-linear plot shown and indicated a
t1¤2 of 94 days for plasma cells in the bone marrow and 172 days for plasma cells in the spleen.
(B) The total number of virus-specific plasma cells in the spleen and bone marrow of irradiated/reconstituted LCMV-immune BALB/c mice
were compared to nonirradiated controls at 240 days postirradiation. Each bar represents the number of virus-specific plasma cells in the
spleen or bone marrow of individual mice. After reconstitution with naive IgHb B cells, no LCMV-specific IgHb-secreting plasma cells were
detected by the ELISPOT assay.
(C) After irradiation, LCMV immune mice (IgHa) were reconstituted with allotypic (IgHb) spleen and bone marrow cells. At 240days postirradiation/
reconstitution, flow cytometry showed that the host IgHa-bearing B cells were completely replaced by naive allotypic IgHb-bearing B cells.
Each sample was double-stained for the B cell marker B220 (vertical axis) and the allotypic (donor) marker IgMb (horizontal axis). The contour
plot represents 30,000 gated events.
(D) Spleen and bone marrow cells from irradiated LCMV-immune mice (240 days postirradiation) were depleted of Ig1 or MHC class II1 cells
by panning on antibody-coated plates. This procedure depleted more than 95% of mature B cells but did not decrease the number of ASC
scored by the ELISPOT assay, indicating that these LCMV-specific ASC have the phenotype of plasma cells.
(Figure 4). These results show that a substantial number plasma cells (1.5 3 104 per recipient) were adoptively
transferred into naive nonirradiated mice, and the kinet-of plasma cells can survive for more than a year without
replenishment by memory B cells and that at least a ics of the resulting serum antibody responses were mon-
itored. There are few to no memory B cells in the bonesubpopulation of plasma cells can survive and continue
to secrete antibody for the natural lifespan of the im- marrow (Shepherd and Noelle, 1991; Paramithiotis and
Cooper, 1997), but as a precaution, bone marrow cellsmune host.
were treated with an antiproliferative agent, mitomycin
C, prior to transfer. Mitomycin C causes a permanentPlasma Cell Survival Following Adoptive Transfer
loss in proliferation by means of its covalent interactionsAdoptive transfer of bone marrow containing LCMV-
with DNA (Tomasz et al., 1974) and has been shown tospecific plasma cells served as an additional approach
for determining plasma cell longevity. Virus-specific block LCMV-specific memory B cell function (Slifka and
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Figure 5. Adoptive Transfer of LCMV-Specific Plasma Cells ResultsFigure 4. Persistence of LCMV-Specific Antibody Production by
in Prolonged Antibody ProductionLong-Lived Plasma Cells
Bone marrow from LCMV-immune mice (containing 1.5 3 104 LCMV-At 80 days postinfection, LCMV-immune C57BL/6 Thy1a IgHa mice
specific plasma cells) was adoptively transferred into naive BALB/cwere given 800 rad of total-body irradiation followed by an intrave-
recipients, and virus-specific serum IgG levels were measured bynous injection of naive C57BL/6 (IgHb) B cells, T cells, and bone
ELISA. The bone marrow cells were treated with an antiproliferativemarrow. After irradiation, LCMV-specific memory B cells were unde-
agent, mitomycin C, prior to transfer. Plasma cell half-life estimatestectable by limiting dilution analysis (,1 memory B cell per 106
in individual mice were fit by the model A(t) 5 [k/(a 2 p)][e2pt 2spleen cells), and no LCMV-specific donor (IgHb) antibody was de-
e2at]. The open circles show antibody levels in individual mice thattected in the serum (data not shown). LCMV-specific serum IgG
received mitomycin C±treated cells; the filled circles show the lacktiters were monitored longitudinally in individual mice (each symbol
of a detectable antibody response (,10 ELISA units) in mice thatdenotes a mouse) by ELISA for more than 500 days postirradiation,
received sonicated bone marrow cells. This demonstrated that theand the survival of virus-specific plasma cells was determined by
antibody response observed after bone marrow transfer was duethe mathematical model described in Figure 2.
to the transfer of plasma cells and not due to passively transferred
antibody or viral antigen.
Ahmed, 1996a). As shown in Figure 5, LCMV-specific
IgG levels initially increased until reaching equilibrium
about 15 days after transfer.Antiviral antibody titers then cells into naive mice. These results show that plasma
cells survive for much longer than previously believedgradually declined over the following 4-month period of
observation while remaining at readily detectable levels. and are an important constituent of long-term humoral
immunity. Although some studies have proposed thatThe decay rate of plasma cells was estimated using
a simple mathematical model describing the adoptive plasma cells may survive longer than a few days or
weeks (Miller, 1964; Okudaira and Ishizaka, 1981; Ho ettransfer system (see Experimental Procedures), and the
results of this experiment indicated a mean plasma cell al., 1986; Manz et al., 1997), the current consensus has
remained that plasma cells have a rapid turnover ratet1¤2 of 74 days.
Antibody production was not due to passively trans- (Szakal et al., 1989; Tew et al., 1990; MacLennan et al.,
1992; Stites et al., 1994; Gray et al., 1996; Zinkernagelferred antibody or transferred viral antigen, because if
bone marrow cells were sonicated prior to transfer, no et al., 1996).
Why do our conclusions differ from previously pub-LCMV-specific antibody could be detected in the recipi-
ents (,10 ELISA units). In addition, if mice received lished observations (Cooper, 1961; Schooley, 1961; Ma-
kela and Nossal, 1962; Nossal and Makela, 1962), whichmitomycin C±treated LCMV-immune bone marrow (or
spleen cells) and were later challenged with LCMV, no show that plasma cells are short-lived? The previously
established paradigm is based on studies that analyzedmemory B cell responses could be detected (data not
shown). Collectively, these data indicate that in the ab- the lifespan of plasma cells during theacute phase of the
humoral response (the first 2 weeks after vaccination), asence of memory B cells, adoptively transferred plasma
cells have an extended lifespan and sustain prolonged time when B cells are rapidly expanding, differentiating
into ASC, and being depleted during clonal selectionantibody production in otherwise naive recipients. These
results also suggest that plasma cells continue to se- and affinity maturation (Kelsoe, 1996). During this period
there also appears to be migration of plasma cells fromcrete antibody for extended periods of time in the ab-
sence of detectable antigen. the spleen and lymph nodes to the bone marrow com-
partment. If we restrict our analysis to this early period
(days 8±30 postinfection), when the number of LCMV-Discussion
specific plasma cells are rapidly declining in the spleen
(Figure 1), then we also observe an apparently short half-This quantitative study of plasma cell longevity demon-
strates that plasma cells can survive for periods longer life for plasma cells (t1¤2 5 5.7 days). This is in contrast to
the estimated plasma cell half-life in the spleen fromthan 1 year. In addition, this study also relates the life-
span of antigen-specific plasma cells located in different days 60±300 postinfection (t1¤2 5 172 days), as shown in
Figure 3A. Thus, the previous studies were correct inanatomical sites to the level of specific antibody ob-
served in theserum. Two experimental approaches were determining the lifespan of plasma cells at early time
points after antigenic stimulation, but they did not accu-used in these studies; irradiation/reconstitution of im-
mune mice and adoptive transfer of virus-specific plasma rately reflect the lifespan of plasma cells found during
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the later stages of a humoral immune response, once marrow are long-lived (Figure 3). Since the lifespan of
mice is only 2±3 years, antibody production for 1±1.5homeostasis is achieved. It makes intuitive sense that
plasma cells generated during the early stages of the years by long-lived plasma cellsconstitutes a significant
portion of the animal's life (Figure 4). It remains to beimmune response are short-lived since it would not be
advantageous to have long-lived antibody responses of seen how these numbers can be extrapolated to plasma
cell longevity in humans, but it is tempting to speculatepoor specificity and/or low affinity. On the other hand,
it would be more advantageous for ASC that survive the that the prolonged antibody responses seen after hu-
man vaccination with inert antigens are due to long-clonal selection and affinity maturation process to be
long-lived, since these cells would provide a powerful lived plasma cells.
Our findings on plasma cell longevity address somefirst line of defense against microbial pathogens.
It is well documented that microbial infections often interesting issues of aging. In our experiments monitor-
ing plasma cell survival, we found that the rate of plasmainduce prolonged serum antibody responses (Plotkin
and Mortimer, 1988; Ahmed and Gray, 1996; Slifka and cell decline was similar irrespective of age and that the
half-life of plasma cells in young mice, at 2±4 monthsAhmed, 1996b). The sustained antibody production
against microbes has commonly been attributed to re- of age, was essentially the same as that in old mice, at
12±26 months of age (Figure 4). This new finding stronglypeated exposure to thepathogen or to low-grade persis-
tence of the microbe (Slifka and Ahmed, 1996b). In the suggests that plasma cell longevity is not affected by
aging. Since it is well established that the ability to gen-case of nonreplicating antigens, such as diphtheria or
tetanus toxoid, long-lasting antibody responses arealso erate new immune responses is greatly impaired in aged
individuals, our results highlight a dichotomy betweeninduced. For example, people vaccinated against either
diptheria or tetanus can maintain circulating antibody the maintenance of preexisting plasma cells and the
ability to generate new ones as a function of age. Whatlevels for more than 25 years (Gottlieb et al., 1964; Kjeld-
sen et al., 1985). Although antibody titers decline over this means is that if an individual is well vaccinated at
an early age and generates a large number of long-livedtime in these individuals, it is extraordinary that circulat-
ing serum antibody can still be detected for decades plasma cells, then this mechanism may be sufficient to
maintain long-term humoral immunity later in life, whenafter immunization with a noninfectious antigen. It has
been proposed that long-term antibody responses are the ability to mount new immune responses might be
impaired.due to continuous stimulation of memory B cells by
antigen±antibody complexes that persist on follicular In addition to documenting the existence of long-lived
plasma cells, our study also defines the quantitativedendritic cells (Szakal et al., 1989; MacLennan et al.,
1992; Gray, 1993). Though plausible, this theory would relationship between antigen-specific memory B cells
and plasma cells. For instance, we can estimate the raterequire an extremely high rate of memory B cell prolifera-
tion and differentiation into plasma cells (see below). It at which memory B cells must proliferate in order to
maintain the stable numbers of LCMV-specific memoryis also difficult to understand how antigen trapped on
follicular dendritic cellswould persist in an immunogenic B cells and plasma cells observed in mice following
immunization (Figure 1). To maintain a stable populationform for such long periods of time and why it would not
be consumed by the continuous stimulation of memory of memory B cells (M), the rate at which new memory
B cells are generated by proliferation (r M) must equalB and T cells. Thus the existing models, all of which
assume that plasma cells are short-lived, do not offer the rate at which they are lost due to their differentiation
into plasma cells and the natural death rate of memorya satisfactory explanation of how long-term antibody
responses are maintained. B cells. To maintain a stable population of plasma cells,
the rate of generation of plasma cells by differentiationIn agreement with our data describing long-lived
plasma cells, a recent study (Manz et al., 1997) has used of memory B cells must, in turn, equal the rate at which
they die (p P). Assuming that the natural death rate ofbromodeoxyuridine (BrdU) incorporation during booster
vaccination to monitor plasma cell survival in the bone memory B cells is small, we estimate the amount of
memory B cell proliferation required to maintain themarrow. Manz et al. provide convincing evidence for
long-lived plasma cells and show that more than 60% plasma cell population from the equation r M 5 d P (this
is a lower bound to the rate of memory Bcell proliferationof BrdU1 plasma cells in the bone marrow survive at
least 90 days without turnover. Although a specific half- because we have neglected the natural death rate of
this population). Converting to half-lives for the turnoverlife was not calculated, the existence of plasma cells
that survive for longer than 3 months was clearly docu- rates of memory B cells (Tm) and plasma cells (Tp),
we obtain Tm 5 Tp M/P. From Figure 1, we obtain anmented. In ourstudy, we examined plasma cell longevity
for the life of the mouse (z2 years), and our experimental estimate of the total number of plasma cells (P 5 4 3
104) and memory B cells (M 5 1.5 3 104), assuming thatstrategy, in conjunction with mathematical modeling,
allowed us to obtain a precise estimate of the half-life of half the memory B cells are in the spleen and half are
in the lymph nodes. Inserting these values into the equa-antigen-specific plasma cells. In addition, we examined
plasma cell lifespan in both spleen and bone marrow tion above, we find that Tm 5 (0.37)Tp. If plasma cells
were short-lived (t1¤2 5 3±5 days), then each LCMV-spe-compartments. This is an important point, because an
earlier study suggested that bone marrow plasma cells cific memory B cell must divide approximately every
1.5 days in order to sustain the observed plasma cellmay have a lifespan of 3±4 weeks whereas splenic
plasma cells appeared to have a half-life of only a few populations. However, if plasma cells are long-lived
(t1¤2 5 100 days), as we have shown in this study, thendays (Ho et al., 1986). In contrast, our studies show
unequivocally that plasma cells in both spleen and bone memory B cells would need to divide only once every
Immunity
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San Diego, CA). The half-life of IgG molecules was determined by35 days in order to maintain the observed plasma cell
transferring 0.5 ml of pooled LCMV-immune serum (after clarificationnumbers. This latter result is more consistent with pub-
by centrifugation at 14,000 rpm, for 5 min) intraperitoneally intolished observations of memory B cell turnover (Schittek
naive BALB/c recipients.
and Rajewsky, 1990; Vieira and Rajewsky, 1990) and
demonstrates that plasma cell longevity is critical in Plasma Cell Lifespan Estimation from the Decay
maintaining immunological homeostasis as well as per- of Serum Antibody Levels
Irradiation results in the elimination of memory B cells and the losssistent antibody production.
of a small fraction, f, of plasma cells. Using a simple mathematicalIt will be interesting to determine what conditions in-
model that incorporates these processes (provided that the rate offluence the longevity of antigen-specific plasma cells.
secretion of antibody per plasma cell remains constant and that the
It is possible that the anatomical microenvironment population of plasma cells decays exponentially with rate p), the
plays a role in determining the lifespan of plasma cells. decay in antibody will follow a biexponential decay described by
For example, serum antibody responses are generally the function A(t) 5 [A(0)/(a 2 p)][a(1 2 f)e2pt 1 (af 2 p)e2at]. A(0) and
a were set to the preirradiation antibody level and the rate constantmaintained for a much greater period of time than muco-
for the decay of transferred antibody, respectively. The biexponen-sal antibody responses (Slifka and Ahmed, 1996b). This
tial decay has an initially rapid decay rate due to the loss of amay be due to the support of serum antibody production
fraction, f, of the plasma cells upon irradiation, followed by a slower
primarily by plasma cells in the bone marrow, whereas decay rate due to the loss of plasma cells at rate p. The rate of
mucosal antibody levels mostly reflect the number of antibody decay, a, was determined in an independent experiment
local plasma cells found in mucosal tissues. Short-lived (Figure 3), allowing estimates for the p and f to be obtained for each
individual mouse by fitting their serum antibody concentration tomucosal antibody responses may be due to the migra-
the above function. The rates of decay obtained from fitting thetion of plasma cells to other anatomical sites (such as
data for total IgG from individual BALB/c mice to the biexponentialthe bone marrow), or it is possible that plasma cells at
decay model were p 5 0.0011, 0.0046, 0.0028, and 0.011 day21,
mucosal sites are short-lived. By identifying the factors which resulted in a mean p of 0.005 day21 (SEM 5 0.0023). The
that prolong plasma cell survival, we may be able to average rate of plasma cell decline and SEM were then transformed
increase the potency of suboptimal vaccines and there- to half-lives (t1¤2 5 ln(0.5)/p), which are reported in Results. Similar
results were obtained by ignoring the initial decline in antibody titersby decrease the number of booster vaccinations required
during the first 30 days after irradiation and fitting the later timeto sustain protective immunity. Understanding the mech-
points to a simple exponential decay with rate equal to that for theanisms of plasma cell survival will not only provide fun-
loss of plasma cells.
damental information about these critical cells of the
immune system, but will also have practical implications ELISPOT
for vaccine development. LCMV-specific ASC were quantitated by the ELISPOT technique
using nitrocellulose-bottomed 96-well plates (Millipore, San Fran-
cisco, CA) coated with virus (Slifka et al., 1995).Experimental Procedures
Quantitation of Memory B CellsMice
Virus-specific memory B cells were restimulated with LCMV in vitroBALB/c Byj IgHa, BALB/c IgHb SMN (formerly known as CB.17 mice),
and quantitated by limiting dilution analysis as previously describedC57BL/6 Thy1a IgHa, and C57BL/6 Thy1a (IgHb) mice were purchased
in detail (Slifka and Ahmed, 1996a). In addition to limiting dilutionfrom the Jackson Laboratory (Bar Harbor, ME). The congenital
analysis, adoptive transfer and challenge studies were performed.BALB/c and C57BL/6 carrier colonies were derived from neonatally
Spleen cells were tested for memory B cell activity by transferringinfected mice and bred at Emory University.
2 3 107 total spleen cells intravenously into irradiated (600 rad) naive
recipients followed by challenge with 2 3 105 pfu of LCMV on theVirus
day of transfer. Serum samples were collectedby retroorbital bleed-The Armstrong CA 1371 strain of LCMV was used in this study
ing and tested for virus-specific serum antibody by ELISA. Using(Ahmed et al., 1984). LCMV-immune mice were obtained by injecting
this assay, spleen cells from irradiated/reconstituted LCMV-immune5- to 8-week-old BALB/c mice intraperitoneally with 2 3 105 plaque-
mice did not confer an anamnestic antibody response upon chal-forming units (pfu) of LCMV Armstrong. C57BL/6 Thy1a IgHa mice
lenge. Instead, transfer of spleen cells from irradiated/reconstitutedwere infected with the same dose of LCMV at 20 weeks of age.
immune mice resulted in the kinetics of a primary antibody response
that was indiscernible from that after transfer of an equal numberIrradiation and Reconstitution
of naive spleen cells.At 60 days postinfection, LCMV-immune mice received total-body
irradiation (96 rad/min from a Gammacell-40 irradiator) [Nordion
Evaluation of B Cell Reconstitution by Flow CytometryInternational] for a total dose of 600 rad) to deplete LCMV-specific
Flow cytometry was performed as previously described (Ahmed etmemory B cells. BALB/c mice were reconstituted with 3 3 107 allo-
al., 1988) using anti-B220-cychrome, anti-IgMa-phycoerythrin (datatypic BALB/c IgHb spleen cells and 2 3 107 bone marrow cells within
not shown), and anti-IgMb-fluorescein isothiocyanate antibodies4 hr after irradiation by intravenous injection. C57BL/6 Thy1a IgHa
(PharMingen) and gating on live cells. Each flow cytometry profilemice received 800 rad total-body irradiation followed by reconstitu-
shows 30,000 gated events and is representative of three individualtion with 3 3 107 spleen cells and 1 3 107 bone marrow cells from
mice assayed separately.naive C57BL/6 mice. At 3 months after irradiation/transfer, LCMV-
immune mice were fully reconstituted with mature B cells and T
cells, but if rechallenged with the same strain of LCMV (106 pfu of In Vitro B Lymphocyte Depletion
virus injected intraperitoneally), no anamnestic antibody responses Plates used for B cell depletion were prepared by coating polysty-
were detected. rene Petri dishes (Falcon) with either anti-IgG, anti-IgM, anti-IgA (5
mg/ml, Cappell) or anti±MHC class II (PharMingen, 8 mg/ml) in 0.05
M Tris-HCl, 0.15 M NaCl (pH 5 9.5) overnight at 48C. Plates wereELISA
At the indicated time points, serum was collected from individual washed to remove unbound antibody and blocked 5±10 min with
phosphate-buffered saline (PBS)±5% fetal calf serum (FCS) prior tomice by retroorbital bleeding, and LCMV-specific serum antibody
titers were determined by a solid-phase ELISA as described pre- addition of 3 ml of cells suspended in PBS±5% FCS (10±25 3 106
cells/ml). Cells were allowed to adhere for 90 min at 48C. Nonadher-viously (Ahmed et al., 1984). Allotype-specific responses were ana-
lyzed using IgG2aa- and IgG2ab-specific antibodies (PharMingen, ant cells were removed from the plates by gentle pipetting and used
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in ELISPOT assays for quantitating LCMV-specific ASC. More than Anderson, R.E., and Lefkovits, I. (1980). Effects of irradiation on the
in vitro immune response. Exp. Cell. Biol. 48, 255±278.95% of mature B cells were removed by this procedure. Depletion
was determined by staining for B2201Ig1 cells and quantitating by Bachmann, M.F., Kundig, T.M., Kalberer, C.P., Hengartner, H., and
flow cytometry. Zinkernagel, R.M. (1994). How many specific B cells are needed to
protect against a virus? J. Immunol. 152, 4235±4241.
Benner, R., Hijmans, W., and Haaijman, J.J. (1981). The bone mar-Adoptive Transfer of LCMV-Specific Plasma Cells
row: the major source of serum immunoglobulins, but still a ne-Bone marrow from LCMV-immune mice was used for the adoptive
glected site of antibody formation. Clin. Exp. Immunol. 46, 1±8.transfer studies because bone marrow contains a large number of
antiviral plasma cells (Slifka et al., 1995) (Figure 1A) and few mature Cooper, E.H. (1961). Production of lymphocytes and plasma cells
B cells. Femoral bone marrow (4 3 107 cells) from LCMV-immune in the rat following immunization with human serum albumin. Immu-
BALB/c mice (4 months after infection) containing 1.5 3 104 antiviral nology 4, 219±231.
plasma cells were adoptively transferred into naive nonirradiated Dilosa, R.M., Maeda, K., Masuda, A., Szakal, A.K., and Tew, J.G.
BALB/c recipients. The number of ASC transferred was determined (1991). Germinal center B cells and antibody production in the bone
by ELISPOT analysis at the time of injection. Bone marrow cells and marrow. J. Immunol. 146, 4071±4077.
spleen cells were treated with mitomycin C (Sigma, St. Louis, MO) Fahey, J.L., and Sell, S. (1965). The immunoglobulins of mice: the
at a concentration of 50 mg/ml in PBS with a final cell concentration metabolic (catabolic) properties of five immunoglobulin classes. J.
of 2.5 3 107 cells/ml at 378C for 20 min. Cells were washed three Exp. Med. 122, 41±58.
times, counted, and injected intravenously into the recipient mice.
Gottlieb, S., McLaughlin, F.X., Levine, L., Latham, W.C., and Edsall,Small serum samples were taken at the indicated time points and
G. (1964). Long-term immunity to tetanus: a statistical evaluationtested for LCMV-specific IgG by ELISA. To determine whether immu-
and its clinical implications. Am. J. Pub. Health 54, 961±971.nogenic viral antigen was transferred with the bone marrow cells,
Gray, D. (1993). Immunological memory: a function of antigen persis-two naive nonirradiated BALB/c mice received 5 3 107 sonicated
tence. Trends Microbiol. 1, 39±41.LCMV-immune bone marrow cells. LCMV-specific serum antibody
Gray, D., Siepmann, K., van Essen, D., Poudrier, J., Wykes, M.,remained below detection in these mice.
Jainandunsing, S., Bergthorsdottir, S., and Dullforce, P. (1996). B-T
lymphocyte interactions in the generation and survival of memoryEstimation of Plasma Cell Longevity Following
cells. Immunol. Rev. 150, 45±61.Adoptive Transfer
Halper, J., Fu, S.M., Wang, C.Y., Winchester, R., and Kunkel, H.G.Assuming that a fixed number of plasma cells are transferred and
(1978). Patterns of expression of human Ia-like antigens during ter-that their number decays thereafter, the initial increase in antibody
minal stages of a B cell development. J. Immunol. 120, 1480±1484.titers would occur as a result of the antibody secretion by the trans-
Helmreich, E., Kern, M., and Eisen, H.N. (1961). The secretion offerred plasma cells. The later decay in antibody levels would occur
antibody by isolated lymph node cells. J. Biol. Chem. 236, 464±473.as a result of the decrease in plasma cell numbers over time. Using
a simple mathematical model that incorporates these processes, Hibi, T., and Dosch, H.M. (1986). Limiting dilution analysis of the
the change in antibody concentration A(t) following transfer can B cell compartment in human bone marrow. Eur. J. Immunol. 16,
139±145.then be described by the function A(t) 5 [k/(a 2 p)][e2pt 2 e2at],
where k equals the product of the number of transferred plasma Ho, F., Lortan, J.E., MacLennan, I., and Khan, M. (1986). Distinct
cells and the rate at which they secrete antibody, and a and p are short-lived and long-lived antibody-producing cell populations. Eur.
the rate constants for decay of antibody and plasma cells, respec- J. Immunol. 16, 1297±1301.
tively. The rate of antibody decay, a, was determined in an indepen- Hyland, L., Sangster, M., Sealy, R., and Coleclough, C. (1994). Respi-
dent experiment (Figure 3), allowing estimates for the p and k for ratory virus infection of mice provokes a permanent humoral immune
each individual recipient mouse by fitting the observed serum anti- response. J. Virol. 68, 6083±6086.
body titers to the function above. The rate constants for the loss of Kelsoe, G. (1996). The germinal center: a crucible for lymphocyte
plasma cells obtained from individual mice were p 5 0.014, 0.0046, selection. Semin. Immunol. 8, 179±184.
and 0.0094 day21, giving a mean p of 0.0094 day21 (SEM 5 0.0028),
Kjeldsen, K., Heron, I., and Simonsen, O. (1985). Immunity againstand indicating a mean plasma cell t1¤2 of 74 days. diphtheria 25±30 years after primary vaccination in childhood. Lan-
cet 1, 900±902.
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